Form 13-F position report

PLUS THERAPEUTICS INC

Reported by Ashton Thomas Private Wealth LLC

PSTV CUSIP 72941H509 Manager CIK 0002019663

Reported 0 shares, down 32,913 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2026
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 3 Through Q2 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-06-30 6605
2022-09-30 5442
2022-12-31 3877
2023-03-31 3547
2023-06-30 0
2024-06-30 1198
2024-09-30 18853
2024-12-31 0
2025-12-31 12763
2026-03-31 5352
2026-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

11 quarters
Quarterly reported position history for PLUS THERAPEUTICS INC held by Ashton Thomas Private Wealth LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Reduced 0 -32,913 (-100.0%) 0 $0 2026-07-29
Q1 2026 Added 32,913 +8,000 (32.1%) < 0.01% $5,352 2026-05-11
Q4 2025 New 24,913 +24,913 (0.0%) < 0.01% $12,763 2026-01-29
Q4 2024 Reduced 0 -12,913 (-100.0%) 0 $0 2025-02-07
Q3 2024 Added 12,913 +12,098 (1484.4%) < 0.01% $18,853 2024-11-05
Q2 2024 New 815 +815 (0.0%) < 0.01% $1,198 2024-08-07
Q2 2023 Reduced 0 -12,230 (-100.0%) 0 $0 2024-04-23
Q1 2023 Unchanged 12,230 0 (0.0%) < 0.01% $3,547 2024-04-23
Q4 2022 Unchanged 12,230 0 (0.0%) < 0.01% $3,877 2024-04-22
Q3 2022 Unchanged 12,230 0 (0.0%) < 0.01% $5,442 2024-04-22
Q2 2022 New 12,230 +12,230 (0.0%) < 0.01% $6,605 2024-04-22

Who else reported the position

24 managers reported PLUS THERAPEUTICS INC for Q2 2026.

Managers reporting PLUS THERAPEUTICS INC in Q2 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Cambridge Investment Research Advisors Inc Reduced 0 -13,450 0 $0 4 qtrs
ADVISOR GROUP HOLDINGS INC Reduced 0 -133 0 $0 13 qtrs
DAGCO Inc Reduced 0 -25,882 0 $0 4 qtrs
Citigroup Inc Reduced 0 -93,002 0 $0 3 qtrs
Kestra Advisory Services LLC Reduced 0 -25,800 0 $0 4 qtrs
Barclays PLC Reduced 0 -2 0 $0 2 qtrs
Sound Income Strategies LLC Reduced 0 -28 0 $0 3 qtrs
XTX Topco Ltd Reduced 0 -116,023 0 $0 3 qtrs
BlackRock Inc Reduced 0 -1,776,372 0 $0 8 qtrs
MILLENNIUM MANAGEMENT LLC Reduced 0 -271,599 0 $0 2 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2026
Filed
July 29, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.